UK Parliament / Open data

Breast Cancer Drugs

Proceeding contribution from Mary Creagh (Labour) in the House of Commons on Thursday, 26 January 2017. It occurred during Backbench debate on Breast Cancer Drugs.

I congratulate my hon. Friend on securing this debate. She certainly makes a powerful speech on behalf of her friend. Does she agree that when NICE looks at the cost-value ratio, stories such as that of her friend, who kept eight people in work, should also be a factor? We should be looking at women’s economic life and economic role, in both the workplace and the home.

Type
Proceeding contribution
Reference
620 c506 
Session
2016-17
Chamber / Committee
House of Commons chamber
Back to top